Contract Development and Manufacturing Services
Whether you need an innovative solution for an early phase product or the cGMP framework and regulatory history to support commercial manufacturing, we are the CDMO you can always depend on. With over 20 years helping life science and pharmaceutical companies deliver their products to patients, we are dedicated to your success because the drugs and devices you are developing are too important to ever go unrealized.
Our Specialized CDMO Solutions
Our fully integrated teams have the experience to meet the unique manufacturing demands of your product. You can depend on our dedication to providing quality products with a focus on regulatory compliance, customer service, and above all else, patient safety.
LSNE focuses on developing manufacturing processes that are scalable, reproducible, and commercially robust. We utilize a Quality by Design (QbD) approach to provide you with a product that meets your critical quality attributes. Whether you are facing solubility or stability challenges, we can develop and optimize your formulation for any parenteral route of administration. If lyophilization is required to support the long-term stability of your product, LSNE can develop a lyophilization cycle to provide you with a commercially elegant presentation of your product. Whatever your product type, we have the experience to navigate the risks and guide you to success.
Pharmaceutical Manufacturing Services
For more than two decades, we have built our reputation as the go-to, full-service CDMO that our clients trust with their manufacturing needs. Through the years, we earned that reputation by providing insightful guidance and a robust infrastructure to deliver on the most challenging products on time and on budget.
LSNE delivers unmatched quality to our clients around the world. We perform rigorous analytical testing services to support in-process, release, and ICH stability testing. To further your testing needs, we can perform analytical method development, support efficient method transfers, and phase appropriate validation.